.jpg)
1 hour ago
3
Article content
OTTAWA, Ontario — BIOTECanada concluded BIONATION 2026 this week at the National Arts Centre in Ottawa, convening senior biotechnology and life sciences leaders with policymakers, elected officials, investors, researchers, and partners for two days of discussion on the sector’s strategic role in Canada’s economy, health security, and competitiveness.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Article content
This year’s program focused on what it takes for Canadian biotechnology companies to grow from Canada, compete globally, and bring innovation closer to patients. Discussions examined access to investment capital, efficient regulatory pathways, market access, dual-use life sciences technologies, and AI-enabled drug development, with early-stage companies sharing candid perspectives on the decisions they face as they scale while global pharmaceutical companies highlighted their contributions to Canada’s innovation ecosystem and their role in bringing new therapies to Canadian patients.
Article content
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
“BIONATION made clear that Canada’s biotechnology sector isn’t waiting for the future, it’s building it now,” said Wendy Zatylny, President and CEO of BIOTECanada. “There was a real sense of Canadian pride in the room, but also a clear understanding that success doesn’t happen by accident. The right policy, investment, regulatory, and access conditions will determine how much of this innovation reaches patients and creates value here at home, including evaluation and pricing frameworks that recognize the full value of innovation while supporting timely access to new therapies.” BIONATION also featured the BIOTECanada Gold Leaf Awards, recognizing outstanding Canadian leadership and achievement across the biotechnology sector. This year’s recipients were Xenon Pharmaceuticals Inc., Biotech Company of the Year; Ripple Therapeutics, Promising Biotech Company of the Year; Dr. Allen Eaves, Industry Leadership; Dr. Massimiliano Paganelli and Dr. Claudia Raggi, Community Leadership; and Gordon McCauley, Leadership.
Article content
“BIONATION reflects the strength and ambition of Canada’s biotechnology sector,
Article content
” said Oliver Technow, Chair of the BIOTECanada Board of Directors. “
Article content
The forum brought members and decision-makers into direct conversation about what companies need to build and grow in Canada. This year’s discussions reinforced the scale of the opportunity before Canada and the urgent importance of ensuring Canadian innovation is supported, scaled, and positioned to compete globally.
Article content
”
Article content
As countries compete for talent, investment, health security, and life sciences capacity, BIONATION reinforced biotechnology’s strategic importance to Canada. BIOTECanada will continue working with members, government, and sector partners to support the conditions that help Canadian innovations reach patients and create value here at home.
Article content
Article content
About BIOTECanada
Article content
BIOTECanada is the national industry association voice. With over 200 members, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges. Visit: biotech.ca
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content
Contacts
Article content
Media contact:
Article content
Article content
Nina Lewis
Article content
Article content
Manager of Communications, BIOTECanada
Article content
Article content
Article content
English (US)